ライフサイエンスコーパス: mucinous

1 t (496 serous invasive, 139 endometrioid, 86 mucinous).

2 us, 1.11 endometrioid, 1.26 clear cell, 0.94 mucinous].

3 , and clear cell [1.37 (1.18-1.58)], but not mucinous [0.99 (0.88-1.10), P-heterogeneity = 0.01] tumo

4 rade serous (HGS), 2,100 endometrioid, 1,591 mucinous, 1,034 clear cell, and 1,016 low-grade serous,

5 cancer (2,045 serous, 319 endometrioid, 184 mucinous, 121 clear cell, 577 other/unknown).

6 ntified (3,378 serous, 606 endometrioid, 331 mucinous, 269 clear cell, 1,000 other).

7 was noted between endometriosis and risk of mucinous (31 [6.0%] of 516 cases, 1.02, 0.69-1.50, p=0.9

8 of 1140 cases, 1.20, 0.95-1.52, p=0.12, and mucinous 65 [8.5%] of 767 cases, 1.12, 0.84-1.48, p=0.45

9 ficantly worse cancer-specific survival than mucinous adenocarcinoma and nonmucinous adenocarcinoma p

10 The solid malignancies included 2 cases of mucinous adenocarcinoma of the colon, 1 each of metastat

11 Mucinous adenocarcinoma of the lung is a subtype of high

12 mary cutaneous mucinous carcinoma," "primary mucinous adenocarcinoma of the skin," "primary mucinous

13 the model also displayed a low incidence of mucinous adenocarcinoma, a rare variant type of human pr

14 lly have cystic components; and (d) invasive mucinous adenocarcinoma, histopathologically showing lep

15 ogy (38.1% vs. 26.7% non-mucinous, and 26.9% mucinous adenocarcinoma, P < 0.001), removing < 12 lymph

16 impact, especially in patients with stage IV mucinous adenocarcinoma.

17 d between the right and left colon; 62% were mucinous adenocarcinoma.

18 al transition program leading to an invasive mucinous adenocarcinoma.

19 alveolar carcinomas are now called "invasive mucinous adenocarcinoma." Because the lung cancer field

20 Less frequent subtypes include mucinous adenocarcinomas (MAC) and signet-ring cell carc

21 Mucinous adenocarcinomas develop 5 to 30 weeks after inf

22 tage IV moderately and poorly differentiated mucinous adenocarcinomas have distinctly different CSS a

23 combine moderately and poorly differentiated mucinous adenocarcinomas into a single mucinous high-gra

24 prognostic impact of histological grade for mucinous adenocarcinomas is primarily restricted to stag

25 of PI3K results in hyperplasia and invasive mucinous adenocarcinomas.

26 ifferentiated histology were more common for mucinous adenocarcinomas.

27 ce that were phenotypically similar to human mucinous adenocarcinomas.

28 istant microthrombi in patients with occult, mucinous adenocarcinomas.

29 e particularly implicated in the etiology of mucinous and endometrioid carcinomas.

30 mong colorectal adenocarcinomas, 10%-15% are mucinous and have worse prognoses than nonmucinous ones.

31 gnostic approach should focus on identifying mucinous and malignant cysts.

32 A significant difference between benign mucinous and malignant mucinous cysts was observed (p =

33 quent (32.1%, versus 12.1% in DGCs), as were mucinous and neuroendocrine carcinomas, carcinoma with l

34 romise in the ability to distinguish between mucinous and nonmucinous cysts.

35 ave improved accuracy to distinguish between mucinous and nonmucinous cysts.

36 Though overall CSS was similar for mucinous and nonmucinous subtypes, differences in stage

37 pillary carcinomas); and group C (medullary, mucinous and papillary carcinomas).

38 YC amplification was detected in both of the mucinous and the Brenner components; MYC amplification a

39 fering associations for hormonal factors and mucinous and tubular cancers suggest etiologies distinct

40 l ovarian tumors (six endometrioid and three mucinous) and their corresponding normal DNA as well as

41 , 836 lobular, 639 mixed ductal-lobular, 216 mucinous, and 132 tubular breast cancers were diagnosed.

42 d signet-ring histology (38.1% vs. 26.7% non-mucinous, and 26.9% mucinous adenocarcinoma, P < 0.001),

43 ovarian cancer histotypes (low grade serous, mucinous, and clear cell carcinomas), the inability to d

44 ssociated with decreased risk of clear cell, mucinous, and endometrioid subtype, but not with the mos

45 marker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts.

46 The incidence of mucinous appendiceal adenocarcinomas (MAA) has increased

47 have a major prognostic impact in metastatic mucinous appendiceal adenocarcinomas, the prognostic imp

48 ic cyst fluid biomarker to differentiate non-mucinous, benign mucinous, and malignant mucinous cysts.

49 ours and the large size and heterogeneity of mucinous borderline tumours which may result in an invas

50 Former mucinous bronchioloalveolar carcinomas are now called "i

51 types of ovarian cancer but not in HOSE and mucinous cancer cells.

52 The relative risks for ductal and mucinous cancers were 1.63 (95% CI 1.55-1.72) and 1.58 (

53 -lobular, 492 tubular, 71 medullary, and 148 mucinous cancers; and 1913 (14%) were in situ, including

54 ines are not available for primary cutaneous mucinous carcinoma (PCMC).

55 ma) lesions and one precancerous (pancreatic mucinous carcinoma) lesion were detected.

56 10 with low-grade serous carcinoma, 207 with mucinous carcinoma, 484 with endometrioid carcinoma, and

57 Search terms were "primary cutaneous mucinous carcinoma," "primary mucinous adenocarcinoma of

58 rom an in situ lesion to a classic, invasive mucinous carcinoma.

59 ferentiation and the other was pure invasive mucinous carcinoma.

60 plicated in the etiology of endometrioid and mucinous carcinoma.

61 s; ii) low-grade serous carcinomas; and iii) mucinous carcinomas and malignant Brenner tumors.

62 n situ component, 7 (44%) were pure invasive mucinous carcinomas, and 5 (31%) demonstrated both growt

63 r the diagnosis and the prognosis of colonic mucinous carcinomas.

64 ous, low-grade endometrioid, clear-cell, and mucinous carcinomas.

65 serous carcinomas from high-grade serous and mucinous carcinomas.

66 hemotherapy treatment (P < .001), peritoneal mucinous carcinomatosis (PMCA) histopathologic subtype (

67 ma peritonei (PMP) is an uncommon peritoneal mucinous carcinomatosis confined to the peritoneal cavit

68 One patient with mucinous cardiopathy died of acute heart failure.

69 cases from 65% (based on CA125) to 82%, and mucinous cases from 44% to 88%.

70 ing high and low grade serous, endometrioid, mucinous, clear cell, and granulosa cell carcinomas and

71 We recorded no significant associations for mucinous, clear-cell, or low-grade serous carcinoma.

72 e tumors were strikingly similar to invasive mucinous colon cancers in humans.

73 PDG are distinct gland-like mucinous compartments with a distinct molecular signatur

74 indolent tumor types (islet cell tumors and mucinous cystadenocarcinoma).

75 rozygous WT/Trp53(R172H) mice also presented mucinous cystadenocarcinomas at 12 weeks of age, recapit

76 nd pathology surprisingly revealed a biliary mucinous cystadenoma.

77 ), solid pseudopapillary neoplasms(12%), and mucinous cystadenomas (6%).

78 is a very good marker for the presence of a mucinous cystic lesion, it is not an indicator of malign

79 rent understanding of the natural history of mucinous cystic lesions, and includes the current use an

80 raductal papillary mucinous neoplasm [IPMN], mucinous cystic neoplasm [MCN]).

81 2012 international consensus guidelines for mucinous cystic neoplasm and intraductal papillary mucin

82 lack of ovarian-type stroma in a pancreatic mucinous cystic neoplasm and the presence of pleomorphic

83 uctal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm were updated in 2012, incorpora

84 Pathological examination revealed a mucinous cystic neoplasm with a component of an undiffer

85 Mucinous (intraductal mucinous neoplasm or mucinous cystic neoplasm) lesions have malignant potenti

86 AC, ampullary carcinoma, cholangiocarcinoma, mucinous cystic neoplasm, chronic inflammation, and chro

87 Mucinous cystic neoplasm-associated adenocarcinoma appea

88 Pathologies included: 35 mucinous cystic neoplasms (adenoma 28, borderline 7), 22

89 tal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasive neopla

90 Pancreatic mucinous cystic neoplasms (MCNs) harbor malignant potent

91 ductal papillary mucinous neoplasms (IPMNs), mucinous cystic neoplasms (MCNs), and solid pseudopapill

92 uid samples were obtained from patients with mucinous cystic neoplasms (n=17), intraductal papillary

93 ical characteristics of intrahepatic biliary mucinous cystic neoplasms and to establish eligible diag

94 Intrahepatic biliary mucinous cystic neoplasms are rare and preoperative diag

95 Biliary mucinous cystic neoplasms are rare cystic lesions of the

96 Intrahepatic biliary mucinous cystic neoplasms are rare hepatic tumors and ac

97 novel pancreatic lesion resembling low-grade mucinous cystic neoplasms in humans.

98 Biliary mucinous cystic neoplasms require a high index of suspic

99 discriminated mucin-producing cystic tumors (mucinous cystic neoplasms+intraductal papillary mucinous

100 intraductal papillary mucinous neoplasms, 43 mucinous cystic neoplasms, and 36 non-mucinous cysts) fr

101 intraductal papillary mucinous neoplasms and mucinous cystic neoplasms, have the potential to progres

102 cysts may be intraductal mucinous neoplasms, mucinous cystic neoplasms, serous cystadenomas, solid ps

103 ian Brenner tumors often are associated with mucinous cystic neoplasms, which are hypothesized to sha

104 intraductal papillary mucinous neoplasms and mucinous cystic neoplasms, while pancreatic intraepithel

105 we review the current literature on biliary mucinous cystic neoplasms, with a particular emphasis on

106 Only few case reports of mucinous cystic pancreatic neoplasm containing an undiff

107 ly discriminate between SCA and premalignant mucinous cysts (intraductal papillary mucinous neoplasm

108 f 112 patients with histologically confirmed mucinous cysts of the pancreas evaluated in a single ter

109 Mucinous cysts require further differentiation to allow

110 osis and bile duct metaplasia with extensive mucinous cysts throughout all lobes, and induction of ch

111 None of the invasive cancers arising from mucinous cysts was <3 cm.

112 erence between benign mucinous and malignant mucinous cysts was observed (p = 0.025).

113 expressed in the cyst fluid of patients with mucinous cysts were CEA (median FI: IPMN 11.4, MCN 13.0,

114 ms, 43 mucinous cystic neoplasms, and 36 non-mucinous cysts) from patients undergoing surgery at 4 te

115 gical assessment of predicting malignancy in mucinous cysts, particularly in small BD IPMN.

116 are benign and can be monitored clinically, mucinous cysts, such as intraductal papillary mucinous n

117 non-mucinous, benign mucinous, and malignant mucinous cysts.

118 gh-grade dysplastic cysts compared to benign mucinous cysts.

119 Scleromyxedema is a rare mucinous deposition disorder that shares clinical featur

120 of colonic stem cell markers LGR5 and PROM1, mucinous differentiation, and metastasis.

121 sis had been diagnosed with invasive serous, mucinous, endometrioid, or clear-cell carcinomas of the

122 r use of HRT was greater for serous than for mucinous, endometroid, or clear cell tumours (1.53 [1.31

123 .11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioi

124 ignificant association with disease stage in mucinous EOC subtypes (p = 0.009), lymph node involvemen

125 nd muscular hypertrophy, parietal cell loss, mucinous epithelial cell metaplasia, and massive eosinop

126 ecommend BRCA testing for all women with non-mucinous epithelial ovarian cancer, there is significant

127 at first birth was unassociated with risk of mucinous (for >/=30 years vs. 20-24 years, HR = 0.62, 95

128 ponse to injury, PDG undergo an Shh-mediated mucinous gastrointestinal metaplasia with PanIN-like fea

129 al and phenotypic peculiarities: (i) CRIS-A: mucinous, glycolytic, enriched for microsatellite instab

130 Lubricin, a mucinous glycoprotein encoded by the PRG4 gene, provides

131 Mucin 1 (MUC1) is a mucinous glycoprotein expressed at the surfaces of epith

132 nt accompanied by a reduction in elastin and mucinous ground-substance content.

133 iated mucinous adenocarcinomas into a single mucinous high-grade category, is not known.

134 1.40]), high tumor grade (1.34 [1.16-1.55]), mucinous histological type (1.27 [1.08-1.50]), and nodal

135 pendiceal adenocarcinomas, of which 1375 had mucinous histology and 860 had nonmucinous histology.

136 DDX21 expression levels correlated with non-mucinous histology in early stage cancers but not with o

137 The strikingly higher frequency of mucinous histology suggests that the biology of CRC diff

138 Advanced stage and mucinous histology were significant predictors of advers

139 ized by right-sided location, multifocality, mucinous histology, and lymphocytic infiltration.

140 ican Joint Committee on Cancer stage, signet/mucinous histology, and poor/undifferentiated grade.

141 1.14-2.34] and 4.94 (95% CI: 3.32-7.35) for mucinous histology, in comparison with 1.44 (95% CI: 0.8

142 nce of lymphovascular or perineural invasion,mucinous histology, number of vascular pedicles, and use

143 SMAD4 mutations were associated with mucinous histology.

144 ically poor - early stage cases and those of mucinous histology.

145 neoadjuvant chemotherapy, onset of PMs, and mucinous histology.

146 tis and multifocal, right-sided cancers with mucinous histopathology, similar to human MMR-deficient

147 oid and serous histotypes was higher than in mucinous histotypes, consistent with results of immunohi

148 Nkx2-1-negative murine lung tumors mimic mucinous human lung adenocarcinomas, which express gastr

149 Mucinous (intraductal mucinous neoplasm or mucinous cyst

150 carcinoma (Braf), endometrioid (Ctnnb1), or mucinous (Kras) carcinomas.

151 th formation of two distinct types of TC and mucinous lesions.

152 h' sensations [1], in part, by breaking down mucinous lubricating proteins in saliva [2,3].

153 12 weeks induced the expansion of PDGs with mucinous metaplasia and columnar cell atypia resembling

154 e architecture and chronic pancreatitis with mucinous metaplasia and increased formation of murine Pa

155 itis, acinar to ductal metaplasia (ADM), and mucinous metaplasia that resembles PanIN1a.

156 PDG may provide a link between Shh, mucinous metaplasia, and neoplasia.

157 nt of chronic inflammation, hyperplasia, and mucinous metaplasia, and, later in life, of pseudointest

158 ons (MDL) are called tubular complexes (TC), mucinous metaplasia, or pancreatic intraepithelial neopl

159 xpansion of the PDG compartment results in a mucinous metaplasia.

160 bular complexes and for lesions exhibiting a mucinous metaplasia.

161 fferentiation is identified in a minority of mucinous metaplastic lesions.

162 AREG levels for non-mucinous (n = 6), benign mucinous (n = 15), and cancerous cysts (n = 15) were 85

163 amples, the median (IQR) AREG levels for non-mucinous (n = 6), benign mucinous (n = 15), and cancerou

164 d a pancreatic lesion: intraductal papillary mucinous neoplasia (14 patients, 35%) and pancreatic duc

165 t of tumors resembling intraductal papillary mucinous neoplasia (IPMN), a precursor to PDAC in humans

166 malignant or invasive intraductal papillary mucinous neoplasia (IPMN).

167 ed a high incidence of intraductal papillary mucinous neoplasia and active fibrosis compared with Pdx

168 ient had a synchronous intraductal papillary mucinous neoplasia and pancreatic ductal adenocarcinoma.

169 enocarcinoma and 2 for intraductal papillary mucinous neoplasia), while the remaining 35 are under co

170 ph nodes, a context of intraductal papillary mucinous neoplasia, and vascular resections were indepen

171 BACKGROUND & AIMS: Intraductal papillary mucinous neoplasias (IPMNs) are precancerous cystic lesi

172 (</=30 mm) branch-duct intraductal papillary mucinous neoplasm (BD IPMN; 67%), whereas also being spe

173 for the management of intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm we

174 nt of branch duct (BD) intraductal papillary mucinous neoplasm (IPMN) espouse safety of observation o

175 ic duct (MPD)-involved intraductal papillary mucinous neoplasm (IPMN) has been established by surgica

176 eatic branch-duct (BD) intraductal papillary mucinous neoplasm (IPMN) is infrequent and that extrapan

177 re similar to those of intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

178 neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN) precursor lesions.

179 Human intraductal papillary mucinous neoplasm (IPMN) specimens were analyzed by immu

180 tic lesions resembling intraductal papillary mucinous neoplasm (IPMN) were observed as early as 2 mon

181 s preneoplastic lesion intraductal papillary mucinous neoplasm (IPMN), to find new microRNA (miRNA)-b

182 ncreatic resection for intraductal papillary mucinous neoplasm (IPMN).

183 inoma in patients with intraductal papillary mucinous neoplasm (IPMN).

184 Intraductal papillary mucinous neoplasm (particularly the branch duct variant)

185 ignant mucinous cysts (intraductal papillary mucinous neoplasm [IPMN], mucinous cystic neoplasm [MCN]

186 s for the treatment of intraductal papillary mucinous neoplasm and cystic lesions of the pancreas app

187 Intraductal papillary mucinous neoplasm and pancreatic neuroendocrine tumor bi

188 us cystic neoplasm and intraductal papillary mucinous neoplasm are superior to the original 2006 guid

189 ly one patient with an intraductal papillary mucinous neoplasm had high-grade dysplasia.

190 If the mucinous neoplasm is minimally invasive and cytoreductio

191 Mucinous (intraductal mucinous neoplasm or mucinous cystic neoplasm) lesions h

192 Intraductal papillary mucinous neoplasm patients appear to have cancer risk in

193 itonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous d

194 rs, two Brenner tumors not associated with a mucinous neoplasm, and two atypical proliferative (borde

195 e commonly detected in intraductal papillary mucinous neoplasm-associated PDACs.

196 Smad4 both regulate an intraductal papillary mucinous neoplasm-to-PDAC sequence through distinct tumo

197 ndocrine tumors (35%), intraductal papillary mucinous neoplasms (33%), solid pseudopapillary neoplasm

198 28, borderline 7), 22 intraductal papillary mucinous neoplasms (adenoma 9, borderline 9, cancer 4),

199 cially for branch duct intraductal papillary mucinous neoplasms (BD-IPMNs), remain uncertain.

200 lopment of branch duct intraductal papillary mucinous neoplasms (BD-IPMNs).

201 population of resected intraductal papillary mucinous neoplasms (IPMN) of the pancreas with respect t

202 for the management of intraductal papillary mucinous neoplasms (IPMN) recommend surgical treatment i

203 section for pancreatic intraductal papillary mucinous neoplasms (IPMN) using targeted next-generation

204 s, 2 cysts/remnants, 4 intraductal papillary mucinous neoplasms (IPMN), 2 adenocarcinomas, 1 low-grad

205 e origin of pancreatic intraductal papillary mucinous neoplasms (IPMN).

206 mors (PanNET, n = 42), intraductal papillary mucinous neoplasms (IPMN, n = 20), and ampulla of Vater

207 ations are reported in intraductal papillary mucinous neoplasms (IPMNs) and in McCune-Albright syndro

208 Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms

209 AC precursors known as intraductal papillary mucinous neoplasms (IPMNs) and predictors of their patho

210 Among PCNs, Intraductal Papillary Mucinous Neoplasms (IPMNs) are common lesions that may p

211 Intraductal papillary mucinous neoplasms (IPMNs) are the most frequent cystic

212 iagnostic criterion of intraductal papillary mucinous neoplasms (IPMNs) involving the main duct (MD I

213 radiographic imaging, Intraductal Papillary Mucinous Neoplasms (IPMNs) of the pancreas are identifie

214 Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas arising in br

215 ed in association with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.

216 increased detection of intraductal papillary mucinous neoplasms (IPMNs), and their management remains

217 s cystadenomas (SCAs), intraductal papillary mucinous neoplasms (IPMNs), mucinous cystic neoplasms (M

218 elines for branch-duct intraductal papillary mucinous neoplasms (IPMNs).

219 stic neoplasms (n=17), intraductal papillary mucinous neoplasms (n=15), serous cystadenomas (n=12), o

220 ative R0 microinvasive intraductal papillary mucinous neoplasms (without recurrence at 27, 29, and 34

221 ntified in 85 HRIs (82 intraductal papillary mucinous neoplasms and 3 pancreatic endocrine tumors).

222 asia in less than 3 cm intraductal papillary mucinous neoplasms and in multiple intraepithelial neopl

223 ucinous cysts, such as intraductal papillary mucinous neoplasms and mucinous cystic neoplasms, have t

224 leads to predominantly intraductal papillary mucinous neoplasms and mucinous cystic neoplasms, while

225 More cases of intraductal papillary mucinous neoplasms are being diagnosed and studied.

226 endocrine tumors, and intraductal pancreatic mucinous neoplasms are included.

227 Intraductal papillary mucinous neoplasms are increasingly diagnosed cystic pre

228 Intraductal papillary mucinous neoplasms are the most common pancreatic malign

229 ology should be retained for both serous and mucinous neoplasms because of the risk of extraovarian i

230 Intraductal papillary mucinous neoplasms can be multifocal and a potential cau

231 bute to progression of intraductal papillary mucinous neoplasms into malignancies.

232 Mucinous neoplasms of the appendix were found in 5 of 17

233 carcinomas arising in intraductal papillary mucinous neoplasms of the pancreas (IPMN) by histologica

234 esions (ie, high-grade intraductal papillary mucinous neoplasms or grade 3 pancreatic intraepithelial

235 (4/58, 6.9%) than non- intraductal papillary mucinous neoplasms PDAC (5/385, 1.3%) (P = .02).

236 Appendiceal mucinous neoplasms sometimes present with peritoneal dis

237 g malignant pancreatic intraductal papillary mucinous neoplasms were developed based on logistic regr

238 sor neoplasms, such as intraductal papillary mucinous neoplasms with high-grade dysplasia and some en

239 ia, or intestinal-type intraductal papillary mucinous neoplasms with intermediate-grade dysplasia.

240 inous cystic neoplasms+intraductal papillary mucinous neoplasms) from benign cystic lesions (serous c

241 otential (for example, intraductal papillary mucinous neoplasms).

242 adenocarcinoma, 17 had intraductal papillary mucinous neoplasms, 26 had symptomatic chronic pancreati

243 amples of 169 PCLs (90 intraductal papillary mucinous neoplasms, 43 mucinous cystic neoplasms, and 36

244 Pancreatic cysts may be intraductal mucinous neoplasms, mucinous cystic neoplasms, serous cy

245 fluid from pancreatic intraductal papillary mucinous neoplasms, the monoclonal antibody Das-1 identi

246 a larger proportion of intraductal papillary mucinous neoplasms-related tumors (4/58, 6.9%) than non-

247 use pancreas to induce intraductal papillary mucinous neoplasms.

248 ement of patients with Intraductal Papillary Mucinous Neoplasms.

249 the mouse pancreas and prevents formation of mucinous neoplasms.

250 r cystadenofibroma (n = 14; 11 serous, three mucinous); nonneoplastic cysts (n = 5; two endometriomas

251 noma, and the most frequent histotype is the mucinous one.

252 associations with endometrioid but not with mucinous or clear cell cancers.

253 tic infiltrate, and a poorly differentiated, mucinous or signet ring appearance.

254 mg/L was positively associated with risk of mucinous (OR = 9.67; 95% CI = 1.10-84.80) and endometrio

255 diagnosed with clear cell, endometrioid, or mucinous ovarian cancer should be offered somatic tumor

256 idence of serous invasive, endometrioid, and mucinous ovarian cancers in the US Nurses' Health Study

257 Mucinous ovarian carcinoma (MOC) is a unique subtype of

258 ical grades, including benign and borderline mucinous ovarian tumors, and compare these to tumors fro

259 mas at 12 weeks of age, recapitulating human mucinous ovarian tumors, which also exhibit heterozygous

260 denocarcinoma and high-grade dysplasia among mucinous pancreatic cysts are clinically needed.

261 ns, a history of pancreatitis, patients with mucinous pancreatic cysts, and elderly patients with new

262 paclitaxel is effective for the treatment of mucinous pancreatic cysts.

263 n parameters achieved their lowest values in mucinous, papillary and medullary carcinomas, whereas th

264 This pilot study demonstrates that non-mucinous PM of CRC can be visualized intraoperatively us

265 riments were performed on human BTSCs, human mucinous primary CCA cell cultures, and human cholangioc

266 tential O-linked glycosylation sites on this mucinous protein.

267 These findings functionally link mucinous proteins with tumor aggression, and offer a new

268 tumorigenesis and inhibits Kras(G12D)-driven mucinous pulmonary adenocarcinoma.

269 not in PAFR-negative ovarian cells (HOSE and mucinous RMUG-L).

270 ing was associated with an increased risk of mucinous (RR per 20 pack-years, 1.26; 95% CI, 1.08 to 1.

271 Hispanics were more likely to have mucinous/signet-ring type histology (42.5%) than whites

272 P < 0.001), perineural invasion (P < 0.001), mucinous subtype (P = 0.006), and age <60 years (P < 0.0

273 n, showing that LVI and perineural invasion, mucinous subtype, and low age constitute independent ris

274 bmucosal invasion, grade of differentiation, mucinous subtype, lymphovascular, and perineural invasio

275 utility of immunohistochemical subtyping of mucinous sweat gland carcinomas.

276 cinous adenocarcinoma of the skin," "primary mucinous sweat-gland carcinoma," and "endocrine mucin-pr

277 Lubricin is a mucinous, synovial fluid glycoprotein that enables near

278 urs of the two most common types, serous and mucinous, these having a different natural behaviour.

279 erefore, we present the first mouse model of mucinous tumor formation from ovarian cells and supporti

280 hotspot driver mutations specifically in the mucinous tumor.

281 Nine neoplasms were mucinous tumors (64.3%), including all neoplasms associa

282 ce interval: 1.0, 2.4) but decreased risk of mucinous tumors (IRR = 0.3, 95% confidence interval: 0.1

283 Mucinous tumors (n = 18) were the most common malignant

284 d with an increased risk in endometrioid and mucinous tumors [e.g., testosterone, endometrioid tumors

285 ant of adenocarcinoma, intraductal papillary mucinous tumors are observed in patients with McCune-Alb

286 us tumors is associated with size, and small mucinous tumors are very unlikely to be malignant.

287 Malignancy within mucinous tumors is associated with size, and small mucin

288 ordinate variants between paired Brenner and mucinous tumors supports a shared origin or progression.

289 demonstrated that a set of genes induced in mucinous tumors was shared with genes induced in a nontu

290 AS mutations in granulosa cell tumors and in mucinous tumors, respectively.

291 DNA from six Brenner tumors with paired mucinous tumors, two Brenner tumors not associated with

292 erapy, whereas no association was found with mucinous tumors.

293 e a distinct subset of genes was specific to mucinous tumors.

294 ociation of NKX2-1 with the genes induced in mucinous tumors.

295 between ductal type of intraductal papillary mucinous tumors.

296 perative sites and to destroy small residual mucinous tumour nodules, cytoreductive surgery is combin

297 The incidence of mucinous tumours (12% of the total) seemed little affect

298 of ovarian cancer, except for the intestinal mucinous type.

299 tive, double-blind trial of 39 patients with mucinous-type pancreatic cysts.

300 ociated with poorer survival included: clear/mucinous versus serous histology (AHR, 2.79; 95% CI, 1.8